Join
Live feed
·
INSIDERFilingvia Quantisnow
AcelRx Pharmaceuticals Inc. logo

Angotti Vincent J. bought $7,268 worth of shares (10,000 units at $0.73), increasing direct ownership by 11% to 101,805 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ACRX· AcelRx Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACRX (AcelRx Pharmaceuticals Inc.) and more on Quantisnow.